{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:53:12Z","timestamp":1791157992877,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60973-1","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:04:34Z","timestamp":1783181074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional clinical psychological and quality of life benefits of cyclosporine a therapy in patients with moderate-to-severe plaque psoriasis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2936-9300","authenticated-orcid":false,"given":"Wojciech","family":"Kulej","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Michalska-Ba\u0144kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Stefaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Opalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Czupryna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beniamin Oskar","family":"Grabarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"60973_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/biomedicines9111511","volume":"9","author":"A Campanati","year":"2021","unstructured":"Campanati, A. et al. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 9, 1511. https:\/\/doi.org\/10.3390\/biomedicines9111511 (2021).","journal-title":"Biomedicines"},{"key":"60973_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/1744666X.2020.1719833","volume":"16","author":"E Pezzolo","year":"2020","unstructured":"Pezzolo, E. & Naldi, L. Epidemiology of major chronic inflammatory immune-related skin diseases in 2019. Expert Rev. Clin. Immunol. 16, 155\u2013166. https:\/\/doi.org\/10.1080\/1744666X.2020.1719833 (2020).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"60973_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","volume":"18","author":"G Schett","year":"2022","unstructured":"Schett, G. et al. Psoriatic arthritis from a mechanistic perspective. Nat. Rev. Rheumatol. 18, 311\u2013325. https:\/\/doi.org\/10.1038\/s41584-022-00776-6 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"60973_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/PTT.S519420","volume":"15","author":"M Ponikowska","year":"2025","unstructured":"Ponikowska, M., Vellone, E., Czapla, M. & Uchmanowicz, I. Challenges Psoriasis and Its Impact on Quality of Life: Challenges in Treatment and Management. Psoriasis (Auckl). 15, 175\u2013183. https:\/\/doi.org\/10.2147\/PTT.S519420 (2025).","journal-title":"Psoriasis (Auckl)"},{"key":"60973_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/brainsci14090865","volume":"14","author":"S Cipolla","year":"2024","unstructured":"Cipolla, S. et al. Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study. Brain Sci. 14, 865. https:\/\/doi.org\/10.3390\/brainsci14090865 (2024).","journal-title":"Brain Sci."},{"key":"60973_CR6","doi-asserted-by":"publisher","first-page":"CD011535","DOI":"10.1002\/14651858.CD011535.pub3","volume":"1","author":"E Sbidian","year":"2020","unstructured":"Sbidian, E. et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst. Rev. 1, CD011535. https:\/\/doi.org\/10.1002\/14651858.CD011535.pub3 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"60973_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00403-024-03425-y","volume":"316","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Clinical features and effects of cyclosporine in the treatment of psoriasis: a systemic review and meta-analysis. Arch. Dermatol. Res. 316, 705. https:\/\/doi.org\/10.1007\/s00403-024-03425-y (2024).","journal-title":"Arch. Dermatol. Res."},{"key":"60973_CR8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s13346-021-01059-5","volume":"12","author":"S Pandey","year":"2022","unstructured":"Pandey, S., Tripathi, P., Gupta, A. & Yadav, J. S. A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine. Drug Deliv Transl Res. 12, 1541\u20131555. https:\/\/doi.org\/10.1007\/s13346-021-01059-5 (2022).","journal-title":"Drug Deliv Transl Res."},{"key":"60973_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4103\/idoj.idoj_189_22","volume":"13","author":"M Rajagopalan","year":"2022","unstructured":"Rajagopalan, M. et al. Role of Cyclosporine (CsA) in Immuno-dermatological Conditions. Indian Dermatology Online J. 13, 585\u2013599 (2022).","journal-title":"Indian Dermatology Online J."},{"key":"60973_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/CCID.S286312","volume":"14","author":"B Kowalewska","year":"2021","unstructured":"Kowalewska, B., Jankowiak, B., Cybulski, M., Krajewska-Ku\u0142ak, E. & Khvorik, D. F. Effect of Disease Severity on the Quality of Life and Sense of Stigmatization in Psoriatics. Clin. Cosmet. Investig Dermatol. 14, 107\u2013121. https:\/\/doi.org\/10.2147\/CCID.S286312 (2021).","journal-title":"Clin. Cosmet. Investig Dermatol."},{"key":"60973_CR11","first-page":"S14","volume":"33","author":"V Oji","year":"2015","unstructured":"Oji, V. & Luger, T. A. The skin in psoriasis: assessment and challenges. Clin. Exp. Rheumatol. 33, S14\u201319 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"60973_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40257-021-00653-0","volume":"23","author":"AD Burden","year":"2022","unstructured":"Burden, A. D., Choon, S. E., Gottlieb, A. B., Navarini, A. A. & Warren, R. B. Clinical Disease Measures in Generalized Pustular Psoriasis. Am. J. Clin. Dermatol. 23, 39\u201350. https:\/\/doi.org\/10.1007\/s40257-021-00653-0 (2022).","journal-title":"Am. J. Clin. Dermatol."},{"key":"60973_CR13","first-page":"21","volume":"102","author":"SS Kolli","year":"2018","unstructured":"Kolli, S. S., Amin, S. D., Pona, A., Cline, A. & Feldman, S. R. Psychosocial impact of psoriasis: a review for dermatology residents. Cutis 102, 21\u201325 (2018).","journal-title":"Cutis"},{"key":"60973_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/ced.15116","volume":"47","author":"GH Wren","year":"2022","unstructured":"Wren, G. H., Humby, T., Thompson, A. R. & Davies, W. Mood symptoms, neurodevelopmental traits, and their contributory factors in X-linked ichthyosis, ichthyosis vulgaris and psoriasis. Clin. Exp. Dermatol. 47, 1097\u20131108. https:\/\/doi.org\/10.1111\/ced.15116 (2022).","journal-title":"Clin. Exp. Dermatol."},{"key":"60973_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/13548506.2020.1766093","volume":"26","author":"F Hassani","year":"2021","unstructured":"Hassani, F., Koraei, A., Yaghoobi, R. & Zarea, K. An evaluating of the relationship between body image, body satisfaction, depression, marital quality, and self-esteem in patients with psoriasis. Psychol. Health Med. 26, 467\u2013477. https:\/\/doi.org\/10.1080\/13548506.2020.1766093 (2021).","journal-title":"Psychol. Health Med."},{"key":"60973_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09546634.2020.1757017","volume":"33","author":"F Marsili","year":"2022","unstructured":"Marsili, F. et al. Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study. J. Dermatolog Treat. 33, 401\u2013407. https:\/\/doi.org\/10.1080\/09546634.2020.1757017 (2022).","journal-title":"J. Dermatolog Treat."},{"key":"60973_CR17","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.3390\/healthcare12232484","volume":"12","author":"A Je\u017cuchowska","year":"2024","unstructured":"Je\u017cuchowska, A. et al. The Impact of Mood Disorders on Adherence, on Life Satisfaction and Acceptance of Illness-Cross-Sectional Observational Study. Healthc. (Basel). 12, 2484. https:\/\/doi.org\/10.3390\/healthcare12232484 (2024).","journal-title":"Healthc. (Basel)"},{"key":"60973_CR18","doi-asserted-by":"publisher","unstructured":"ColomboMD, Cassano, N., Bellia, G. & VenaGA Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches. ScientificWorldJournal 2013 (805705). https:\/\/doi.org\/10.1155\/2013\/805705 (2013).","DOI":"10.1155\/2013\/805705"},{"key":"60973_CR19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter, A. et al. Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J. Am. Acad. Dermatol. 82, 1445\u20131486. https:\/\/doi.org\/10.1016\/j.jaad.2020.02.044 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60973_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay, A. Y. & Khan, G. K. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin. Exp. Dermatol. 19, 210\u2013216. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x (1994).","journal-title":"Clin. Exp. Dermatol."},{"key":"60973_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/0277-9536(84)90158-8","volume":"18","author":"BJ Felton","year":"1984","unstructured":"Felton, B. J., Revenson, T. A. & Hinrichsen, G. A. Stress and coping in the explanation of psychological adjustment among chronically ill adults. Soc. Sci. Med. 18, 889\u2013898. https:\/\/doi.org\/10.1016\/0277-9536(84)90158-8 (1984).","journal-title":"Soc. Sci. Med."},{"key":"60973_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","volume":"49","author":"E Diener","year":"1985","unstructured":"Diener, E., Emmons, R. A., Larsen, R. J. & Griffin, S. The Satisfaction With Life Scale. J. Pers. Assess. 49, 71\u201375. https:\/\/doi.org\/10.1207\/s15327752jpa4901_13 (1985).","journal-title":"J. Pers. Assess."},{"key":"60973_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke, K., Spitzer, R. L. & Williams, J. B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16, 606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x (2001).","journal-title":"J. Gen. Intern. Med."},{"key":"60973_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer, R. L., Kroenke, K., Williams, J. B. W. & L\u00f6we, B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 166, 1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092 (2006).","journal-title":"Arch. Intern. Med."},{"key":"60973_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2006.065763","volume":"66","author":"V Chandran","year":"2007","unstructured":"Chandran, V., Bhella, S., Schentag, C. & Gladman, D. D. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann. Rheum. Dis. 66, 936\u2013939. https:\/\/doi.org\/10.1136\/ard.2006.065763 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"60973_CR26","doi-asserted-by":"publisher","DOI":"10.4324\/9781315881089.ch180","author":"A \u0160tulhofer","year":"2010","unstructured":"\u0160tulhofer, A., Bu\u0161ko, V. & Brouillard, P. The New Sexual Satisfaction Scale and Its Short Form. Routledge Handbooks Online. https:\/\/doi.org\/10.4324\/9781315881089.ch180 (2010).","journal-title":"Routledge Handbooks Online"},{"key":"60973_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2133.2007.08296.x","volume":"158","author":"AWM Evers","year":"2008","unstructured":"Evers, A. W. M. et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br. J. Dermatol. 158, 101\u2013108. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08296.x (2008).","journal-title":"Br. J. Dermatol."},{"key":"60973_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0190-9622(89)70007-4","volume":"20","author":"IH Ginsburg","year":"1989","unstructured":"Ginsburg, I. H. & Link, B. G. Feelings of stigmatization in patients with psoriasis. J. Am. Acad. Dermatol. 20, 53\u201363. https:\/\/doi.org\/10.1016\/s0190-9622(89)70007-4 (1989).","journal-title":"J. Am. Acad. Dermatol."},{"key":"60973_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","volume":"132","author":"AY Finlay","year":"1995","unstructured":"Finlay, A. Y. & Coles, E. C. The effect of severe psoriasis on the quality of life of 369 patients. Br. J. Dermatol. 132, 236\u2013244. https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb05019.x (1995).","journal-title":"Br. J. Dermatol."},{"key":"60973_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2340\/0001555575240243","volume":"75","author":"MA Gupta","year":"1995","unstructured":"Gupta, M. A. & Gupta, A. K. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 75, 240\u2013243. https:\/\/doi.org\/10.2340\/0001555575240243 (1995).","journal-title":"Acta Derm Venereol."},{"key":"60973_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2340\/00015555-1265","volume":"92","author":"A Reich","year":"2012","unstructured":"Reich, A. et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 92, 497\u2013501. https:\/\/doi.org\/10.2340\/00015555-1265 (2012).","journal-title":"Acta Derm Venereol."},{"key":"60973_CR32","unstructured":"Sample Size Calculator n.d. https:\/\/www.calculator.net\/sample-size-calculator.html?type=1&cl=95&ci=4.14&pp=2&ps=120000&x=93&y=26(accessed June 14, 2023)."},{"key":"60973_CR33","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.3390\/jcm13216424","volume":"13","author":"N Rompoti","year":"2024","unstructured":"Rompoti, N. et al. Psychopathological Profile of Patients with Moderate-to-Severe Plaque Psoriasis and Its Correlation to DLQI: Results from a Prospective, Monocentric Clinical Study. J. Clin. Med. 13, 6424. https:\/\/doi.org\/10.3390\/jcm13216424 (2024).","journal-title":"J. Clin. Med."},{"key":"60973_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/PTT.S328447","volume":"12","author":"B Blackstone","year":"2022","unstructured":"Blackstone, B., Patel, R. & Bewley, A. Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician. Psoriasis (Auckl). 12, 25\u201333. https:\/\/doi.org\/10.2147\/PTT.S328447 (2022).","journal-title":"Psoriasis (Auckl)"},{"key":"60973_CR35","doi-asserted-by":"crossref","unstructured":"Schlachter, S., Sommer, R., Augustin, M., Tsianakas, A. & Westphal, L. A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis. Acta Dermato-Venereologica ;103. (2023).","DOI":"10.2340\/actadv.v103.3962"},{"key":"60973_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13555-020-00363-1","volume":"10","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak, B., Kowalewska, B., Krajewska-Ku\u0142ak, E. & Khvorik, D. F. Stigmatization and Quality of Life in Patients with Psoriasis. Dermatol. Ther. (Heidelb). 10, 285\u2013296. https:\/\/doi.org\/10.1007\/s13555-020-00363-1 (2020).","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"60973_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00403-022-02420-5","volume":"315","author":"ND Boswell","year":"2023","unstructured":"Boswell, N. D., Cook, M. K., Balogh, E. A. & Feldman, S. R. The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review. Arch. Dermatol. Res. 315, 699\u2013706. https:\/\/doi.org\/10.1007\/s00403-022-02420-5 (2023).","journal-title":"Arch. Dermatol. Res."},{"key":"60973_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1159\/000531420","volume":"239","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study. Dermatology 239, 802\u2013810. https:\/\/doi.org\/10.1159\/000531420 (2023).","journal-title":"Dermatology"},{"key":"60973_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/09546634.2019.1654068","volume":"32","author":"VWY Lai","year":"2021","unstructured":"Lai, V. W. Y., Chen, G. & Sinclair, R. Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata. J. Dermatolog Treat. 32, 250\u2013257. https:\/\/doi.org\/10.1080\/09546634.2019.1654068 (2021).","journal-title":"J. Dermatolog Treat."},{"key":"60973_CR40","doi-asserted-by":"publisher","first-page":"880201","DOI":"10.3389\/fimmu.2022.880201","volume":"13","author":"J Bu","year":"2022","unstructured":"Bu, J., Ding, R., Zhou, L., Chen, X. & Shen, E. Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review. Front. Immunol. 13, 880201. https:\/\/doi.org\/10.3389\/fimmu.2022.880201 (2022).","journal-title":"Front. Immunol."},{"key":"60973_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/13591053241252216","volume":"30","author":"C Flinn","year":"2025","unstructured":"Flinn, C., McInerney, A. & Nearchou, F. The prevalence of comorbid mental health difficulties in young people with chronic skin conditions: A systematic review and meta-analysis. J. Health Psychol. 30, 652\u2013679. https:\/\/doi.org\/10.1177\/13591053241252216 (2025).","journal-title":"J. Health Psychol."},{"key":"60973_CR42","doi-asserted-by":"publisher","first-page":"108893","DOI":"10.1016\/j.surg.2024.07.090","volume":"179","author":"JE Schucht","year":"2025","unstructured":"Schucht, J. E. et al. Beyond Glasgow Coma Scale: Prehospital prediction of traumatic brain injury. Surgery 179, 108893. https:\/\/doi.org\/10.1016\/j.surg.2024.07.090 (2025).","journal-title":"Surgery"},{"key":"60973_CR43","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/bjd.15531","volume":"177","author":"IYK Iskandar","year":"2017","unstructured":"Iskandar, I. Y. K. et al. Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis. Br. J. Dermatol. 177, 1410\u20131421. https:\/\/doi.org\/10.1111\/bjd.15531 (2017).","journal-title":"Br. J. Dermatol."},{"key":"60973_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40801-023-00359-1","volume":"10","author":"S Robinson","year":"2023","unstructured":"Robinson, S. et al. Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study. Drugs Real. World Outcomes. 10, 291\u2013298. https:\/\/doi.org\/10.1007\/s40801-023-00359-1 (2023).","journal-title":"Drugs Real. World Outcomes"},{"key":"60973_CR45","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/09546634.2020.1801977","volume":"33","author":"R Rivera","year":"2022","unstructured":"Rivera, R. et al. Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study. J. Dermatolog Treat. 33, 1329\u20131338. https:\/\/doi.org\/10.1080\/09546634.2020.1801977 (2022).","journal-title":"J. Dermatolog Treat."},{"key":"60973_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ad.2023.07.001","volume":"115","author":"E Daud\u00e9n","year":"2024","unstructured":"Daud\u00e9n, E. et al. Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain. Actas Dermosifiliogr. 115, 1\u20139. https:\/\/doi.org\/10.1016\/j.ad.2023.07.001 (2024).","journal-title":"Actas Dermosifiliogr"},{"key":"60973_CR47","doi-asserted-by":"publisher","first-page":"2247106","DOI":"10.1080\/09546634.2023.2247106","volume":"34","author":"S Min","year":"2023","unstructured":"Min, S., Wang, D., Xia, J., Lin, X. & Jiang, G. The economic burden and quality of life of patients with psoriasis treated with biologics in China. J. Dermatolog Treat. 34, 2247106. https:\/\/doi.org\/10.1080\/09546634.2023.2247106 (2023).","journal-title":"J. Dermatolog Treat."},{"key":"60973_CR48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/medicina60010160","volume":"60","author":"C-L Wu","year":"2024","unstructured":"Wu, C-L., Chang, Y-C., Yao, W-T. & Chiang, T-I. Exploring the Effectiveness of Biological Therapy in Patients with Psoriasis: Body Image and Quality of Life. Med. (Kaunas). 60, 160. https:\/\/doi.org\/10.3390\/medicina60010160 (2024).","journal-title":"Med. (Kaunas)"},{"key":"60973_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/ijd.ijd_241_22","volume":"68","author":"E U\u011furer","year":"2023","unstructured":"U\u011furer, E., Altunay, \u0130. K., \u00d6zkur, E. & Baltan, E. The Effects of Methotrexate and Biologics on the Symptoms of Depression and Anxiety in Patients with Psoriasis. Indian J. Dermatol. 68, 237\u2013244. https:\/\/doi.org\/10.4103\/ijd.ijd_241_22 (2023).","journal-title":"Indian J. Dermatol."},{"key":"60973_CR50","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.3171\/foc.2001.10.1.8","volume":"10","author":"BJ Iskandar","year":"2001","unstructured":"Iskandar, B. J., Fulmer, B. B., Hadley, M. N. & Oakes, W. J. Congenital tethered spinal cord syndrome in adults. Neurosurg. Focus. 10, e7. https:\/\/doi.org\/10.3171\/foc.2001.10.1.8 (2001).","journal-title":"Neurosurg. Focus"},{"key":"60973_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/2475530320924009","volume":"5","author":"MT Wan","year":"2020","unstructured":"Wan, M. T., Pearl, R. L., Chiesa Fuxench, Z. C., Takeshita, J. & Gelfand, J. M. Anticipated and Perceived Stigma Among Patients With Psoriasis. J. Psoriasis Psoriatic Arthritis. 5, 93\u201399. https:\/\/doi.org\/10.1177\/2475530320924009 (2020).","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"60973_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/ijd.ijd_565_22","volume":"68","author":"HT Nguyen","year":"2023","unstructured":"Nguyen, H. T., Ngo, V. T. N., Pham, N. N., Dinh, N. H. & Tran, T. N. A. Sexual Dysfunction and Associated Factors in Women with Psoriasis. Indian J. Dermatol. 68, 121. https:\/\/doi.org\/10.4103\/ijd.ijd_565_22 (2023).","journal-title":"Indian J. Dermatol."},{"key":"60973_CR53","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/medicina58101443","volume":"58","author":"K K\u0119dra","year":"2022","unstructured":"K\u0119dra, K., Janeczko, K., Michalik, I. & Reich, A. Sexual Dysfunction in Women and Men with Psoriasis: A Cross-Sectional Questionnaire-Based Study. Med. (Kaunas). 58, 1443. https:\/\/doi.org\/10.3390\/medicina58101443 (2022).","journal-title":"Med. (Kaunas)"},{"key":"60973_CR54","doi-asserted-by":"publisher","first-page":"adv6485","DOI":"10.2340\/actadv.v103.6485","volume":"103","author":"S Van Beugen","year":"2023","unstructured":"Van Beugen, S. et al. European Society for Dermatology and Psychiatry (ESDaP) Study collaborators. Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries. Acta Derm Venereol. 103, adv6485. https:\/\/doi.org\/10.2340\/actadv.v103.6485 (2023).","journal-title":"Acta Derm Venereol."},{"key":"60973_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/annrheumdis-2017-211625","volume":"77","author":"U-S-D Nguyen","year":"2018","unstructured":"Nguyen, U-S-D. et al. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann. Rheum. Dis. 77, 119\u2013123 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"60973_CR56","doi-asserted-by":"publisher","unstructured":"Duarte, G. V., Calmon, H., Radel, G. & de F\u00e1tima, M. Psoriasis and sexual dysfunction: links, risks, and management challenges. Psoriasis (Auckl). ;8:93\u20139. (2018). https:\/\/doi.org\/10.2147\/PTT.S159916","DOI":"10.2147\/PTT.S159916"},{"key":"60973_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/jamadermatol.2018.3442","volume":"155","author":"A Molina-Leyva","year":"2019","unstructured":"Molina-Leyva, A., Salvador-Rodriguez, L., Martinez-Lopez, A., Ruiz-Carrascosa, J. C. & Arias-Santiago, S. Association Between Psoriasis and Sexual and Erectile Dysfunction in Epidemiologic Studies: A Systematic Review. JAMA Dermatol. 155, 98\u2013106. https:\/\/doi.org\/10.1001\/jamadermatol.2018.3442 (2019).","journal-title":"JAMA Dermatol."},{"key":"60973_CR58","doi-asserted-by":"publisher","unstructured":"Meneghetti, T. C., Carvalho, V. O., de Carvalho, L. M. & Ferriani, V. P. L. Fatigue and the Impact of Musculoskeletal Pain on Quality of Life in Pediatric Patients With Psoriasis. J. Psoriasis Psoriatic Arthritis 2025:24755303251327940. https:\/\/doi.org\/10.1177\/24755303251327940","DOI":"10.1177\/24755303251327940"},{"key":"60973_CR59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/1756-185X.14069","volume":"24","author":"TL Lai","year":"2021","unstructured":"Lai, T. L. et al. Fatigue in psoriatic arthritis: Is it related to disease activity? Int. J. Rheum. Dis. 24, 418\u2013425. https:\/\/doi.org\/10.1111\/1756-185X.14069 (2021).","journal-title":"Int. J. Rheum. Dis."},{"key":"60973_CR60","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.3390\/jcm13247684","volume":"13","author":"B Bie\u0144","year":"2024","unstructured":"Bie\u0144, B., Krajewski, P. K. & Szepietowski, J. C. Patients\u2019 Acceptance of Psoriasis Depends on Disease Severity, Itch Intensity, and the Patients\u2019 Quality of Life: A Cross-Sectional Study. J. Clin. Med. 13, 7684. https:\/\/doi.org\/10.3390\/jcm13247684 (2024).","journal-title":"J. Clin. Med."},{"key":"60973_CR61","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1468-3083.2012.04451.x","volume":"27","author":"D B\u00f6hm","year":"2013","unstructured":"B\u00f6hm, D. et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J. Eur. Acad. Dermatol. Venereol. 27, 220\u2013226. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04451.x (2013).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"60973_CR62","doi-asserted-by":"publisher","first-page":"6879412","DOI":"10.1155\/2019\/6879412","volume":"2019","author":"NS Sawant","year":"2019","unstructured":"Sawant, N. S., Vanjari, N. A. & Khopkar, U. Gender Differences in Depression, Coping, Stigma, and Quality of Life in Patients of Vitiligo. Dermatol. Res. Pract. 2019, 6879412. https:\/\/doi.org\/10.1155\/2019\/6879412 (2019).","journal-title":"Dermatol. Res. Pract."},{"key":"60973_CR63","doi-asserted-by":"publisher","unstructured":"Chen, M. K. et al. Determinants of Quality of Life and Mental Health in Kenyan Psoriasis Patients: A Cross-Sectional Analysis from the Kenyan Psoriasis Registry.J. Psoriasis Psoriatic Arthritis\u00ae. 24755303261433913. https:\/\/doi.org\/10.1177\/24755303261433913 (2026).","DOI":"10.1177\/24755303261433913"},{"key":"60973_CR64","doi-asserted-by":"publisher","unstructured":"Nordgren, M. & Duvetorp, A. Psychosocial impact of climatotherapy in young patients with psoriasis: a 3-month cohort study. Front. Med. 11. https:\/\/doi.org\/10.3389\/fmed.2024.1458394 (2024).","DOI":"10.3389\/fmed.2024.1458394"},{"key":"60973_CR65","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3390\/jcm13164623","volume":"13","author":"G Ghezzi","year":"2024","unstructured":"Ghezzi, G., Costanzo, A. & Borroni, R. G. Health-Related Quality of Life in Psoriasis: Literature Review. J. Clin. Med. 13, 4623. https:\/\/doi.org\/10.3390\/jcm13164623 (2024).","journal-title":"J. Clin. Med."},{"key":"60973_CR66","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/PTT.S516109","volume":"15","author":"P Walniczek","year":"2025","unstructured":"Walniczek, P. et al. Predictors of Quality of Life in Psoriasis Patients: Insights from a Cross-Sectional Study. Psoriasis (Auckl). 15, 163\u2013174. https:\/\/doi.org\/10.2147\/PTT.S516109 (2025).","journal-title":"Psoriasis (Auckl)"},{"key":"60973_CR67","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/CM9.0000000000003841","volume":"139","author":"J Wang","year":"2026","unstructured":"Wang, J. et al. Factors influencing quality of life in patients with psoriasis: A large cross-sectional study. Chin. Med. J. (Engl). 139, 717\u2013727. https:\/\/doi.org\/10.1097\/CM9.0000000000003841 (2026).","journal-title":"Chin. Med. J. (Engl)"},{"key":"60973_CR68","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.2147\/CCID.S543289","volume":"18","author":"A Dymek","year":"2025","unstructured":"Dymek, A. et al. Multidisciplinary Management of Psoriasis: Integrating Diet, Exercise, Psychological Support, and Sleep Interventions. Clin. Cosmet. Investig Dermatol. 18, 2951\u20132970. https:\/\/doi.org\/10.2147\/CCID.S543289 (2025).","journal-title":"Clin. Cosmet. Investig Dermatol."},{"key":"60973_CR69","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.3390\/ijms22062979","volume":"22","author":"N Kanda","year":"2021","unstructured":"Kanda, N. & Psoriasis Pathogenesis, Comorbidities, and Therapy Updated. Int. J. Mol. Sci. 22, 2979. https:\/\/doi.org\/10.3390\/ijms22062979 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"60973_CR70","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/jdv.16915","volume":"34","author":"A Nast","year":"2020","unstructured":"Nast, A. et al. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations. J. Eur. Acad. Dermatol. Venereol. 34, 2461\u20132498. https:\/\/doi.org\/10.1111\/jdv.16915 (2020).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"60973_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5114\/dr.2020.95258","volume":"107","author":"A Reich","year":"2020","unstructured":"Reich, A. et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Przegl Dermatol. 107, 92\u2013108. https:\/\/doi.org\/10.5114\/dr.2020.95258 (2020).","journal-title":"Przegl Dermatol."},{"key":"60973_CR72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5114\/dr.2020.95259","volume":"107","author":"A Reich","year":"2020","unstructured":"Reich, A. et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 2. Przegl Dermatol. 107, 110\u2013137. https:\/\/doi.org\/10.5114\/dr.2020.95259 (2020).","journal-title":"Przegl Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60973-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:45:25Z","timestamp":1791157525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60973-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60973"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60973-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Academy of Silesia, Poland (protocol code 02\/2023; date of approval: 3 March 2023). All participants provided written informed consent prior to enrollment. Patient data were processed in a pseudonymized form; personal identifiers were replaced with unique codes, and the linkage key was stored separately under secure technical and organizational safeguards. Access to the key was restricted to designated investigators (P.M. and A.M.-B.) and used solely for scientific analysis and publication purposes.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30791"}}